List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 270 studies with search of: lung cancer AND new jersey
Hide studies that are not seeking new volunteers.
Hide studies with unknown recruitment status.
  Display Options
Rank Status Study
1 Terminated Docetaxel and Cisplatin in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer
Condition: Lung Cancer
Interventions: Drug: cisplatin;   Drug: docetaxel
2 Completed Gemcitabine and Imatinib Mesylate in Treating Patients With Recurrent or Metastatic Non-Small Cell Lung Cancer
Condition: Lung Cancer
Interventions: Drug: gemcitabine hydrochloride;   Drug: imatinib mesylate
3 Terminated Hydroxychloroquine, Carboplatin, Paclitaxel, and Bevacizumab in Treating Patients With Recurrent Advanced Non-Small Cell Lung Cancer
Condition: Lung Cancer
Interventions: Biological: bevacizumab;   Drug: carboplatin;   Drug: hydroxychloroquine;   Drug: paclitaxel
4 Active, not recruiting Hydroxychloroquine + Carboplatin, Paclitaxel and Bevacizumb in Non-Small Cell Lung Cancer (NSCLC)
Condition: Non-small Cell Lung Cancer
Interventions: Drug: Paclitaxel;   Drug: Carboplatin;   Drug: Hydroxychloroquine;   Drug: Bevacizumab
5 Terminated Medical Nutrition Therapy or Standard Care in Treating Patients With Lung Cancer, Pancreatic Cancer, or Stage III or Stage IV Prostate Cancer
Conditions: Lung Cancer;   Malnutrition;   Pancreatic Cancer;   Prostate Cancer;   Weight Changes
Interventions: Behavioral: compliance monitoring;   Dietary Supplement: dietary intervention;   Dietary Supplement: nutritional intervention;   Drug: chemotherapy;   Other: counseling intervention;   Other: medical chart review;   Other: questionnaire administration;   Other: study of socioeconomic and demographic variables;   Procedure: management of therapy complications;   Procedure: observation;   Procedure: quality-of-life assessment
6 Completed Paclitaxel and Bortezomib in Treating Patients With Metastatic or Unresectable Malignant Solid Tumors
Conditions: Breast Cancer;   Colorectal Cancer;   Head and Neck Cancer;   Lung Cancer;   Melanoma (Skin);   Ovarian Cancer;   Pancreatic Cancer;   Prostate Cancer;   Unspecified Adult Solid Tumor, Protocol Specific
Interventions: Drug: bortezomib;   Drug: paclitaxel
7 Unknown † Comparison of Two Combination Chemotherapy Regimens in Treating Patients With Extensive-Stage Small Cell Lung Cancer
Condition: Lung Cancer
Interventions: Biological: filgrastim;   Drug: cisplatin;   Drug: etoposide;   Drug: irinotecan hydrochloride;   Drug: topotecan hydrochloride
8 Completed Study of Vandetanib Combined With Chemotherapy to Treat Advanced Non-small Cell Lung Cancer
Conditions: Lung Cancer;   Non Small Cell Lung Cancer
Intervention: Drug: vandetanib
9 Completed Interferon Alfa, Isotretinoin, and Paclitaxel in Treating Patients With Recurrent Small Cell Lung Cancer
Condition: Lung Cancer
Interventions: Biological: recombinant interferon alfa;   Drug: isotretinoin;   Drug: paclitaxel
10 Recruiting Airway Epithelium Gene Expression: IDE
Condition: Lung Cancer
Intervention:
11 Terminated Radiosurgery, Temozolomide, and Erlotinib in Treating Patients With Non-Small Cell Lung Cancer and Brain Metastases
Conditions: Lung Cancer;   Metastatic Cancer
Interventions: Drug: erlotinib hydrochloride;   Drug: temozolomide;   Radiation: stereotactic radiosurgery
12 Recruiting Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-Small Lung Cancer That Was Removed By Surgery
Condition: Lung Cancer
Interventions: Biological: bevacizumab;   Drug: cisplatin;   Drug: docetaxel;   Drug: gemcitabine hydrochloride;   Drug: pemetrexed disodium;   Drug: vinorelbine tartrate
13 Recruiting Carboplatin and Paclitaxel With or Without Bevacizumab and/or Cetuximab in Treating Patients With Stage IV or Recurrent Non-Small Cell Lung Cancer
Condition: Lung Cancer
Interventions: Biological: bevacizumab;   Biological: cetuximab;   Drug: carboplatin;   Drug: paclitaxel
14 Recruiting Sunitinib as Maintenance Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer Previously Treated With Combination Chemotherapy
Condition: Lung Cancer
Interventions: Drug: sunitinib malate;   Other: placebo
15 Recruiting Three Different Radiation Therapy Regimens in Treating Patients With Limited-Stage Small Cell Lung Cancer Receiving Cisplatin and Etoposide
Condition: Lung Cancer
Interventions: Radiation: 3-dimensional conformal radiation therapy;   Radiation: intensity-modulated radiation therapy
16 Active, not recruiting Irradiated Donor Lymphocyte Infusion in Treating Patients With Relapsed or Refractory Hematologic Cancer or Solid Tumor
Condition: Cancer
Intervention: Biological: therapeutic allogeneic lymphocytes
17 Recruiting Comparison of Different Types of Surgery in Treating Patients With Stage IA Non-Small Cell Lung Cancer
Condition: Lung Cancer
Interventions: Procedure: therapeutic thoracoscopy;   Procedure: videothoracoscopy
18 Recruiting Pemetrexed and/or Sunitinib as Second-Line Therapy in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
Condition: Lung Cancer
Interventions: Drug: pemetrexed disodium;   Drug: sunitinib malate
19 Recruiting Collection and Storage of Blood and Tissue Samples From Patients Who Are Undergoing Surgery For Lung Cancer
Condition: Lung Cancer
Intervention: Other: biologic sample preservation procedure
20 Recruiting Cisplatin or Carboplatin, and Etoposide With or Without Sunitinib in Treating Patients With Extensive-Stage Small Cell Lung Cancer
Condition: Lung Cancer
Interventions: Drug: carboplatin;   Drug: cisplatin;   Drug: etoposide;   Drug: sunitinib malate

Previous Page Studies Shown (1-20) Next Page (21-40)
† Indicates status has not been verified in more than two years
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
RSS Feeds for studies found by your search that were:
  First received in the last 14 days,  
  Last updated (includes received) in the last 30 days
  Download Options




Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services